• Plasma osteopontin may offer 'reliable biomarker' to predict COVID-19, MIS-C severity

    3 days ago - By Healio

    Plasma osteopontin levels are significantly higher in children hospitalized with moderate to severe COVID-19 and MIS-C than in those with mild or asymptomatic cases, suggesting a potential biomarker for disease severity, researchers said.
    “There are currently no reliable biomarkers for COVID-19 or multisystem inflammatory syndrome, or MIS-C,” Andrew Reisner, MD, of Children's Healthcare of Atlanta and the Emory University School of Medicine, told Healio Rheumatology. “A biomarker, like glucose levels or A1C in a diabetic patient, can help us predict the severity of a
    Read more ...